Davide Bedognetti

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (45)

• Immune microenvironment and non-coding RNA shape early colorectal carcinogenesis in patients with premalignant lesions
  Science Translational Medicine 2026 DOI: 10.1126/scitranslmed.aed2424
  +Save
• Disentangling the relationship between tumor genetic programs and immune responsiveness
  Current Opinion in Immunology 2016 DOI: 10.1016/j.coi.2016.02.001
  +Save
• Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors
  Advanced Healthcare Materials 2016 DOI: 10.1002/adhm.201500606
  +Save
• Pharmacogenetics driving personalized medicine: Analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations
  Journal of Translational Medicine 2016 DOI: 10.1186/s12967-016-0778-z
  +Save
• Inherent transcriptional signatures of NK cells are associated with response to IFNΑ+rivabirin therapy in patients with Hepatitis C Virus
  Journal of Translational Medicine 2015 DOI: 10.1186/s12967-015-0428-x
  +Save
• Prognostic and predictive immune gene signatures in breast cancer
  Current Opinion in Oncology 2015 DOI: 10.1097/CCO.0000000000000234
  +Save
• The immune-related role of BRAF in melanoma
  Journal of Translational Medicine 2015 DOI: 10.1186/1479-5876-13-S1-K19
  +Save
• The ovarian cancer Chemokine landscape is conducive to homing of vaccine-primed and CD3/CD28-Costimulated T cells prepared for adoptive therapy
  Clinical Cancer Research 2015 DOI: 10.1158/1078-0432.CCR-14-2777
  +Save
• Direct T cell-tumour interaction triggers T H 1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme
  British Journal of Cancer 2014 DOI: 10.1038/bjc.2014.235
  +Save
• Impact of carbon nanotubes and graphene on immune cells
  Journal of Translational Medicine 2014 DOI: 10.1186/1479-5876-12-138
  +Save
• Melanoma NOS1 expression promotes dysfunctional IFN signaling
  Journal of Clinical Investigation 2014 DOI: 10.1172/JCI69611
  +Save
• Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
  OncoImmunology 2014 DOI: 10.4161/onci.28727
  +Save
• Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma
  Expert Opinion on Biological Therapy 2014 DOI: 10.1517/14712598.2014.890586
  +Save
• The immune-related role of BRAF in melanoma
  Molecular Oncology 2014 DOI: 10.1016/j.molonc.2014.07.014
  +Save
• The perception of nanotechnology and nanomedicine: A worldwide social media study
  Nanomedicine 2014 DOI: 10.2217/nnm.14.78
  +Save
• BACH2 represses effector programs to stabilize T reg-mediated immune homeostasis
  Rahul Roychoudhuri, Kiyoshi Hirahara, Kambiz Mousavi +27 more
  Nature 2013 DOI: 10.1038/nature12199
  +Save
• CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
  British Journal of Cancer 2013 DOI: 10.1038/bjc.2013.557
  +Save
• Common pathways to tumor rejection
  Annals of the New York Academy of Sciences 2013 DOI: 10.1111/nyas.12063
  +Save
• Functionalized carbon nanotubes as immunomodulator systems
  Biomaterials 2013 DOI: 10.1016/j.biomaterials.2013.02.052
  +Save
• IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
  British Journal of Cancer 2013 DOI: 10.1038/bjc.2013.335
  +Save